EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Adeno-associated viral vector integration: implications for long-term efficacy and safety

Paul Batty, David Lillicrap

Journal of Thrombosis and Haemostasis · 2024

DOI: 10.1016/j.jtha.2024.07.012 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Journal of Thrombosis and Haemostasis, 2024. Verfasst von Paul Batty und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Haematology, Cancer Institute, University College London, London, United Kingdom; Department of Pathology and Molecular Medicine, Queen…. Hauptthemen laut MEDLINE: Dependovirus, Genetic Vectors, Genetic Therapy. Die Arbeit wurde bisher 39-mal zitiert (Crossref) und nennt 96 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Adeno-associated virus (AAV) vector gene therapy provides a promising platform for treatment of monogenic inherited disorders. Clinical studies have demonstrated long-term expression with reduction in bleeding using this approach for the treatment of hemophilia. Despite these advances, there are unknowns surrounding the natural history of recombinant AAV (rAAV) vectors and the cellular mechanisms mediating vector persistence. These unknowns underpin questions regarding long-term efficacy and safety. The predominant mechanism via which AAV is proposed to persist is in circular double-stranded extrachromosomal DNA structures (episomes) within the nucleus. Studies of wild-type AAV (WT-AAV) and rAAV have demonstrated that AAV also persists via integration into a host cell's DNA. It is important to determine whether these integration events can mediate expression or could result in any long-term safety concerns. WT-AAV infection affects a large proportion of the general population, which is thought to have no long-term sequelae. Recent studies have highlighted that this WT-AAV has been detected in cases of acute hepatitis in children and in a minority of cases of hepatocellular carcinoma. Integration following treatment using rAAV has also been reported in preclinical and clinical studies. There have been variable reports on the potential implications of integration for rAAV vectors, with data in some murine studies demonstrating recurrent integration with development of hepatocellular carcinoma. These findings have not been seen in other preclinical or clinical studies. In this review, we will summarize current understanding of the natural history of AAV (wild-type and recombinant) with a focus on genomic integration and cellular implications.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

DependovirusGenetic VectorsGenetic TherapyHumansAnimalsVirus IntegrationHemophilia ATreatment Outcome

Stichwörter der Autor:innen

adeno-associated virusepisomegene therapyhemophilia Avirus integration

Autor:innen und Institutionen

  • Department of Haematology, Cancer Institute, University College London, London, United Kingdom; Department of Pathology and Molecular Medicine, Queen's University, Kingston, Ontario, Canada. Electronic address: paul.bat…
  • Department of Pathology and Molecular Medicine, Queen's University, Kingston, Ontario, Canada.

Zitieren

APA

Batty, P., & Lillicrap, D. (2024). Adeno-associated viral vector integration: implications for long-term efficacy and safety. Journal of Thrombosis and Haemostasis. https://doi.org/10.1016/j.jtha.2024.07.012

Vancouver

Batty P, Lillicrap D. Adeno-associated viral vector integration: implications for long-term efficacy and safety. Journal of Thrombosis and Haemostasis. 2024. doi:10.1016/j.jtha.2024.07.012

BibTeX
@article{Batty2024,
  author = {Batty, Paul and Lillicrap, David},
  title = {Adeno-associated viral vector integration: implications for long-term efficacy and safety},
  journal = {Journal of Thrombosis and Haemostasis},
  year = {2024},
  doi = {10.1016/j.jtha.2024.07.012}
}
Kostenlos starten →